β3-AR stimulation regulated the expression of peroxisome proliferator-activated receptors (PPARs)/mCPT-1 and FAT/CD36, ameliorated liver lipid accumulation, and helped alleviate liver steatosis in NAFLD (Fig. 5). The gene discussed is CPT1B; the disease is fatty liver disease.